Robust Quarterly Organic Revenue Growth of 7.0%,
with an Expansion in Quarter-Over-Quarter Gross Profit Margin of 300 Basis Points,
Generating Net Income of
Achieving Record Adjusted EBITDA of
Third Quarter 2025 Key Figures*
- Revenue of
$195.5 million , an increase of 7.0%, with growth across five largest industries - Gross profit of $58.2 million, up 19.0% or
$9.3 million from$48.9 million , Gross profit margin of 29.8% as compared to 26.8%, an expansion of 300 basis points - Net income of
$13.1 million and Earnings Per Diluted Share of$0.41 - Adjusted EBITDA of
$30.2 million , compared to$23.3 million , an increase of 29.6%; Adjusted EBITDA margin of 15.4% as compared to 12.7%, an expansion of 270 basis points
Year-to-Date 2025 Key Figures*
- Revenue of
$542.6 million , a decrease of 2.6%, yet essentially flat giving effect to the exclusion of voluntary Laboratory consolidations - Gross profit of
$153.0 million , up 4.5% or$6.6 million from$146.4 million , Gross profit margin of 28.2% as compared to 26.3%, an expansion of 190 basis points - Net income of
$12.9 million and Earnings Per Diluted Share of$0.41 - Adjusted EBITDA of
$66.3 million , compared to$61.6 million , an increase of 7.7%; Adjusted EBITDA margin of 12.2% as compared to 11.1%, an expansion of 110 basis points
*All comparisons are consolidated and versus the equivalent prior year period, unless otherwise noted and give effect to the reclassification of certain overhead and personnel expenses in the Unaudited Condensed Consolidated Statements of Income from SG&A to Cost of revenue. Please see the reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures and additional information about the non-GAAP financial measures set forth in tables attached to this press release.
“I am pleased to report our third quarter performance, which resulted in quarterly Adjusted EBITDA of
Third Quarter and First Nine Months 2025 Additional Detailed Highlights:
The Company’s prior year results reflect the reclassification of certain overhead and personnel expenses in the Unaudited Condensed Consolidated Statements of Income, from SG&A to cost of revenue. The reclassification recorded within the financials was
Income from operations was
The Company recorded
Net income was
In the first nine months of 2025, net cash provided by operating activities was
The Company’s gross debt was
2025 Outlook
Although strong revenue growth was achieved in the third quarter, the Company expects full-year 2025 revenue to be between
Adjusted EBITDA has continued to improve and is expected to increase for full-year 2025. Accordingly, the Company is raising its prior qualitative Adjusted EBITDA guidance range of exceeding the 2024 Adjusted EBITDA level of
Conference Call
In connection with this release, MISTRAS will hold a conference call on
About
INVESTORS CONTACT:
Senior Executive Vice President & Chief Financial Officer
+1 (833) MISTRAS | investors@mistrasgroup.com
Forward-Looking and Cautionary Statements
Certain statements contained in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, enhancements in our organizational systems, tools and integrated solutions, the Company's efforts to voluntarily exit unprofitable business and our outlook and expectations for full-year 2025 revenue and Adjusted EBITDA. Such forward-looking statements relate to MISTRAS' financial results and estimates, products and services, business model, operational and strategic initiatives to improve operating leverage, strategy, growth opportunities, profitability and competitive position, and other matters. These forward-looking statements generally use words such as "future," "possible," "potential," "targeted," "anticipate," "believe," "estimate," "expect," "intend," "plan," "predict," "project," "will," "may," "should," "could," "would" and other similar words and phrases. Such statements are not guarantees of future performance or results and will not necessarily be accurate indications of the times at, or by which, such performance or results will be achieved, if at all. These statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in these statements. A list, description and discussion of these and other risks and uncertainties can be found in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended
Use of Non-GAAP Financial Measures
In addition to financial information prepared in accordance with generally accepted accounting principles in the
Unaudited Summary Condensed Consolidated Balance Sheets
(in thousands)
| ASSETS | (unaudited) | |||||
| Cash and cash equivalents | $ | 27,805 | $ | 18,317 | ||
| Accounts receivable, net | 174,787 | 127,281 | ||||
| Other current assets | 34,906 | 26,872 | ||||
| Property, plant and equipment, net | 87,658 | 80,892 | ||||
| 183,725 | 181,442 | |||||
| Other long-term assets | 87,375 | 88,234 | ||||
| Total assets | $ | 596,256 | $ | 523,038 | ||
| LIABILITIES AND EQUITY | ||||||
| Accounts payable | $ | 18,375 | $ | 11,128 | ||
| Current portion of long-term debt | 13,035 | 11,591 | ||||
| Other current liabilities | 94,381 | 92,206 | ||||
| Long-term debt, net of current portion | 189,235 | 158,056 | ||||
| Other long-term liabilities | 53,404 | 51,162 | ||||
| Equity | 227,826 | 198,895 | ||||
| Total liabilities and equity | $ | 596,256 | $ | 523,038 | ||
Unaudited Condensed Consolidated Statements of Income
(in thousands, except per share data)
| Three months ended | Nine months ended | ||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||
| Revenue | $ | 195,549 | $ | 182,694 | $ | 542,569 | $ | 556,909 | |||||
| Cost of revenue | 131,826 | 128,064 | 372,851 | 392,956 | |||||||||
| Depreciation | 5,530 | 5,725 | 16,688 | 17,556 | |||||||||
| Gross profit | 58,193 | 48,905 | 153,030 | 146,397 | |||||||||
| Selling, general and administrative expenses | 33,478 | 33,200 | 108,923 | 105,632 | |||||||||
| Reorganization and other costs | 1,764 | 2,143 | 7,802 | 4,219 | |||||||||
| Environmental expense | 199 | — | 1,257 | — | |||||||||
| Legal settlement and insurance recoveries, net | — | (868 | ) | — | (808 | ) | |||||||
| Research and engineering | 210 | 241 | 778 | 816 | |||||||||
| Depreciation and amortization | 2,161 | 2,331 | 6,473 | 7,170 | |||||||||
| Income from operations | 20,381 | 11,858 | 27,797 | 29,368 | |||||||||
| Other income | — | (1,479 | ) | — | (1,479 | ) | |||||||
| Interest expense | 3,381 | 4,303 | 10,944 | 13,145 | |||||||||
| Income before provision for income taxes | 17,000 | 9,034 | 16,853 | 17,702 | |||||||||
| Provision for income taxes | 3,797 | 2,618 | 3,692 | 3,909 | |||||||||
| Net income | 13,203 | 6,416 | 13,161 | 13,793 | |||||||||
| Less: net income attributable to noncontrolling interests, net of taxes | 95 | 15 | 222 | 28 | |||||||||
| Net income attributable to | $ | 13,108 | $ | 6,401 | $ | 12,939 | $ | 13,765 | |||||
| Net income per common share: | |||||||||||||
| Basic | $ | 0.42 | $ | 0.21 | $ | 0.41 | $ | 0.45 | |||||
| Diluted | $ | 0.41 | $ | 0.20 | $ | 0.41 | $ | 0.44 | |||||
| Weighted-average common shares outstanding: | |||||||||||||
| Basic | 31,543 | 31,002 | 31,361 | 30,895 | |||||||||
| Diluted | 31,880 | 31,660 | 31,920 | 31,513 | |||||||||
Unaudited Operating Data by Segment
(in thousands)
| Three months ended | Nine months ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Revenue | |||||||||||||||
| $ | 160,609 | $ | 149,845 | $ | 437,503 | $ | 456,588 | ||||||||
| International | 35,521 | 33,662 | 107,812 | 100,972 | |||||||||||
| Products and Systems | 4,036 | 3,276 | 9,867 | 9,860 | |||||||||||
| Corporate and Eliminations | (4,617 | ) | (4,089 | ) | (12,613 | ) | (10,511 | ) | |||||||
| Total | $ | 195,549 | $ | 182,694 | $ | 542,569 | $ | 556,909 | |||||||
| Three months ended | Nine months ended | ||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||
| Gross profit | |||||||||||||
| $ | 45,103 | $ | 37,173 | $ | 115,653 | $ | 112,423 | ||||||
| International | 11,190 | 9,912 | 32,548 | 29,068 | |||||||||
| Products and Systems | 2,192 | 1,802 | 5,152 | 4,836 | |||||||||
| Corporate and Eliminations | (292 | ) | 18 | (323 | ) | 70 | |||||||
| Total | $ | 58,193 | $ | 48,905 | $ | 153,030 | $ | 146,397 | |||||
Unaudited Revenues by Category
(in thousands)
Revenue by industry was as follows:
| Three Months Ended | International | Products & Systems | Corp/Elim | Total | |||||||||||
| Oil & Gas | $ | 97,484 | $ | 8,125 | $ | 60 | $ | — | $ | 105,669 | |||||
| Aerospace & Defense | 17,675 | 6,395 | 137 | — | 24,207 | ||||||||||
| Industrials | 15,469 | 6,773 | 360 | — | 22,602 | ||||||||||
| 10,074 | 3,714 | 696 | — | 14,484 | |||||||||||
| Other | 4,722 | 4,014 | 38 | — | 8,774 | ||||||||||
| Infrastructure, Research & Engineering | 5,285 | 3,610 | 1,674 | — | 10,569 | ||||||||||
| Petrochemical | 3,694 | 15 | — | — | 3,709 | ||||||||||
| Other | 6,206 | 2,875 | 1,071 | (4,617 | ) | 5,535 | |||||||||
| Total | $ | 160,609 | $ | 35,521 | $ | 4,036 | $ | (4,617 | ) | $ | 195,549 | ||||
| Three Months Ended | International | Products & Systems | Corp/Elim | Total | |||||||||||
| Oil & Gas | $ | 90,460 | $ | 9,040 | $ | 3 | $ | — | $ | 99,503 | |||||
| Aerospace & Defense | 16,181 | 5,663 | 42 | — | 21,886 | ||||||||||
| Industrials | 12,285 | 6,749 | 478 | — | 19,512 | ||||||||||
| 8,029 | 3,081 | 544 | — | 11,654 | |||||||||||
| Other | 7,836 | 3,900 | 79 | — | 11,815 | ||||||||||
| Infrastructure, Research & Engineering | 5,189 | 2,744 | 797 | — | 8,730 | ||||||||||
| Petrochemical | 3,806 | 198 | — | — | 4,004 | ||||||||||
| Other | 6,059 | 2,287 | 1,333 | (4,089 | ) | 5,590 | |||||||||
| Total | $ | 149,845 | $ | 33,662 | $ | 3,276 | $ | (4,089 | ) | $ | 182,694 | ||||
| Nine Months Ended | International | Products & Systems | Corp/Elim | Total | |||||||||||
| Oil & Gas | $ | 275,849 | $ | 28,714 | $ | 486 | $ | — | $ | 305,049 | |||||
| Aerospace & Defense | 48,530 | 19,690 | 393 | — | 68,613 | ||||||||||
| Industrials | 38,804 | 20,887 | 1,085 | — | 60,776 | ||||||||||
| 22,618 | 6,796 | 1,516 | — | 30,930 | |||||||||||
| Other | 17,100 | 12,930 | 46 | — | 30,076 | ||||||||||
| Infrastructure, Research & Engineering | 12,447 | 10,192 | 3,211 | — | 25,850 | ||||||||||
| Petrochemical | 9,329 | 126 | — | — | 9,455 | ||||||||||
| Other | 12,826 | 8,477 | 3,130 | (12,613 | ) | 11,820 | |||||||||
| Total | $ | 437,503 | $ | 107,812 | $ | 9,867 | $ | (12,613 | ) | $ | 542,569 | ||||
| Nine Months Ended | International | Products & Systems | Corp/Elim | Total | |||||||||||
| Oil & Gas | $ | 289,843 | $ | 31,841 | $ | 240 | $ | — | $ | 321,924 | |||||
| Aerospace & Defense | 48,152 | 18,092 | 100 | — | 66,344 | ||||||||||
| Industrials | 33,047 | 18,480 | 1,478 | — | 53,005 | ||||||||||
| 18,953 | 6,017 | 1,569 | — | 26,539 | |||||||||||
| Other | 26,132 | 12,337 | 155 | — | 38,624 | ||||||||||
| Infrastructure, Research & Engineering | 14,286 | 7,762 | 1,901 | — | 23,949 | ||||||||||
| Petrochemical | 11,467 | 900 | — | — | 12,367 | ||||||||||
| Other | 14,708 | 5,543 | 4,417 | (10,511 | ) | 14,157 | |||||||||
| Total | $ | 456,588 | $ | 100,972 | $ | 9,860 | $ | (10,511 | ) | $ | 556,909 | ||||
Consolidated Revenue by type was as follows:
| Three Months Ended | Nine Months Ended | ||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||
| Revenue by type | |||||||||||
| Field Services | $ | 125,873 | $ | 127,246 | $ | 359,532 | $ | 388,129 | |||
| Laboratories | 16,838 | 15,014 | 47,549 | 49,147 | |||||||
| Data Analytical Solutions | 19,600 | 17,876 | 51,911 | 51,757 | |||||||
| Other | 33,238 | 22,558 | 83,577 | 67,876 | |||||||
| Total | $ | 195,549 | $ | 182,694 | $ | 542,569 | $ | 556,909 | |||
Unaudited Reconciliation of Segment and Total Company Income (Loss) from Operations (GAAP) to
Income (Loss) from Operations before Special Items (non-GAAP)
(in thousands)
| Three months ended | Nine months ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Income from operations (GAAP) | $ | 22,753 | $ | 17,455 | $ | 46,026 | $ | 49,742 | |||||||
| Reorganization and other costs | 283 | 835 | 2,754 | 927 | |||||||||||
| Legal settlement and insurance recoveries, net | — | (868 | ) | — | (808 | ) | |||||||||
| Income from operations before special items (non-GAAP) | $ | 23,036 | $ | 17,422 | $ | 48,780 | $ | 49,861 | |||||||
| International: | |||||||||||||||
| Income from operations (GAAP) | $ | 3,838 | $ | 1,778 | $ | 8,923 | $ | 4,548 | |||||||
| Reorganization and other costs | 171 | 147 | 441 | 410 | |||||||||||
| Income from operations before special items (non-GAAP) | $ | 4,009 | $ | 1,925 | $ | 9,364 | $ | 4,958 | |||||||
| Products and Systems: | |||||||||||||||
| Income from operations (GAAP) | $ | 1,051 | $ | 670 | $ | 1,714 | $ | 1,479 | |||||||
| Reorganization and other costs | — | 182 | 151 | 184 | |||||||||||
| Income from operations before special items (non-GAAP) | $ | 1,051 | $ | 852 | $ | 1,865 | $ | 1,663 | |||||||
| Corporate and Eliminations: | |||||||||||||||
| Loss from operations (GAAP) | $ | (7,261 | ) | $ | (8,045 | ) | $ | (28,866 | ) | $ | (26,401 | ) | |||
| Environmental expense | 199 | — | 1,257 | — | |||||||||||
| Reorganization and other costs | 1,310 | 979 | 4,456 | 2,698 | |||||||||||
| Loss from operations before special items (non-GAAP) | $ | (5,752 | ) | $ | (7,066 | ) | $ | (23,153 | ) | $ | (23,703 | ) | |||
| Income from operations (GAAP) | $ | 20,381 | $ | 11,858 | $ | 27,797 | $ | 29,368 | |||||||
| Environmental expense | 199 | — | 1,257 | — | |||||||||||
| Reorganization and other costs | 1,764 | 2,143 | 7,802 | 4,219 | |||||||||||
| Legal settlement and insurance recoveries, net | — | (868 | ) | — | (808 | ) | |||||||||
| Income from operations before special items (non-GAAP) | $ | 22,344 | $ | 13,133 | $ | 36,856 | $ | 32,779 | |||||||
Unaudited Summary Cash Flow Information
(in thousands)
| Three months ended | Nine months ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net cash provided by (used in): | |||||||||||||||
| Operating activities | $ | 4,462 | $ | 19,356 | $ | 843 | $ | 24,471 | |||||||
| Investing activities | (7,548 | ) | (5,935 | ) | (18,964 | ) | (17,152 | ) | |||||||
| Financing activities | 11,306 | (11,508 | ) | 26,216 | (6,247 | ) | |||||||||
| Effect of exchange rate changes on cash | (372 | ) | 1,270 | 1,393 | 1,642 | ||||||||||
| Net change in cash and cash equivalents | $ | 7,848 | $ | 3,183 | $ | 9,488 | $ | 2,714 | |||||||
Unaudited Reconciliation of Net Cash Provided by Operating Activities (GAAP) to Free Cash Flow (non-GAAP)
(in thousands)
| Three months ended | Nine months ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net cash provided by operating activities (GAAP) | $ | 4,462 | $ | 19,356 | $ | 843 | $ | 24,471 | |||||||
| Less: | |||||||||||||||
| Purchases of property, plant and equipment | (8,532 | ) | (4,716 | ) | (18,534 | ) | (14,315 | ) | |||||||
| Purchases of intangible assets | (874 | ) | (1,428 | ) | (3,166 | ) | (3,832 | ) | |||||||
| Free cash flow (non-GAAP) | $ | (4,944 | ) | $ | 13,212 | $ | (20,857 | ) | $ | 6,324 | |||||
Unaudited Reconciliation of Gross Debt (GAAP) to Net Debt (non-GAAP)
(in thousands)
| Current portion of long-term debt | $ | 13,035 | $ | 11,591 | ||||
| Long-term debt, net of current portion | 189,235 | 158,056 | ||||||
| Total Debt (Gross) | 202,270 | 169,647 | ||||||
| Less: Cash and cash equivalents | (27,805 | ) | (18,317 | ) | ||||
| Total Debt (Net) | $ | 174,465 | $ | 151,330 | ||||
Unaudited Reconciliation of Net Income (GAAP) to Adjusted EBITDA (non-GAAP)
(in thousands)
| Three months ended | Nine months ended | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| Net income (GAAP) | $ | 13,203 | $ | 6,416 | $ | 13,161 | $ | 13,793 | ||||||
| Less: Net income attributable to non-controlling interests, net of taxes | 95 | 15 | 222 | 28 | ||||||||||
| Net income attributable to | $ | 13,108 | $ | 6,401 | $ | 12,939 | $ | 13,765 | ||||||
| Interest expense | 3,381 | 4,303 | 10,944 | 13,145 | ||||||||||
| Income tax (benefit)/expense | 3,797 | 2,618 | 3,692 | 3,909 | ||||||||||
| Depreciation and amortization | 7,691 | 8,056 | 23,161 | 24,726 | ||||||||||
| Share-based compensation expense(1) | 969 | 1,350 | 4,098 | 4,114 | ||||||||||
| Other income | — | (1,479 | ) | — | (1,479 | ) | ||||||||
| Reorganization and other related costs(1) | 1,764 | 2,143 | 7,802 | 4,219 | ||||||||||
| Environmental expense | 199 | — | 1,257 | — | ||||||||||
| Legal settlement and insurance recoveries, net | — | (868 | ) | — | (808 | ) | ||||||||
| Foreign exchange loss (gain) | (735 | ) | 765 | 2,420 | (23 | ) | ||||||||
| Adjusted EBITDA (non-GAAP) | $ | 30,174 | $ | 23,289 | $ | 66,313 | $ | 61,568 | ||||||
_______________
(1) For the three months ended
Unaudited Reconciliation of Net Income (GAAP) and Diluted EPS (GAAP) to
Net Income Excluding Special Items (non-GAAP) and Diluted EPS Excluding Special Items (non-GAAP)
(tabular dollars in thousands, except per share data)
| Three Months Ended | Nine Months Ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net income attributable to | $ | 13,108 | $ | 6,401 | $ | 12,939 | $ | 13,765 | |||||||
| Special items | 1,963 | (204 | ) | 9,059 | 1,932 | ||||||||||
| Tax impact on special items | (462 | ) | 58 | (1,963 | ) | (463 | ) | ||||||||
| Special items, net of tax | $ | 1,501 | $ | (146 | ) | $ | 7,096 | $ | 1,469 | ||||||
| Net income attributable to | $ | 14,609 | $ | 6,255 | $ | 20,035 | $ | 15,234 | |||||||
| Diluted EPS (GAAP)(1) | $ | 0.41 | $ | 0.20 | $ | 0.41 | $ | 0.44 | |||||||
| Special items, net of tax | 0.05 | — | 0.22 | 0.05 | |||||||||||
| Diluted EPS Excluding Special Items (non-GAAP) | $ | 0.46 | $ | 0.20 | $ | 0.63 | $ | 0.49 | |||||||
_______________
(1) For the three months ended

Source: MISTRAS Group, Inc.